NDT Pharmaceuticals Inc. (NDTP)
OTCMKTS · Delayed Price · Currency is USD
0.6731
+0.0631 (10.34%)
At close: Apr 22, 2026
NDT Pharmaceuticals Market Cap
NDT Pharmaceuticals has a market cap or net worth of $128.03 million as of April 23, 2026. Its market cap has increased by 1,160.08% in one year.
Market Cap
128.03M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.67
Market Cap Chart
Since October 21, 2011, NDT Pharmaceuticals's market cap has increased from 2.76M to 128.03M, an increase of 4,539.93%. That is a compound annual growth rate of 30.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 116.03M | -55.97% |
| Dec 31, 2025 | 263.50M | 3,007.18% |
| Dec 31, 2024 | 8.48M | -13.47% |
| Dec 28, 2023 | 9.80M | 1,785.32% |
| Dec 31, 2021 | 519.82K | -69.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 510.90M |
| Silence Therapeutics | 365.12M |
| Northwest Biotherapeutics | 316.75M |
| Vaxart | 182.62M |
| HST Global | 88.40M |
| BioStem Technologies | 78.69M |
| Nuo Therapeutics | 71.01M |
| Cell Source | 53.47M |